
Tumors from ovarian cancer patients receiving neoadjuvant chemotherapy have unique protein profiles that associate with volume of residual disease after interval debulking surgery
Penick, E.R., Rojas, C., Bateman, N.W., Conrads, K.A., Zhou, M., Wang, G., Parikh, N., Huang, Y., Darcy, K.M., Hamilton, C.A., Casablanca, Y., Mhawech-Fauceglia, P., Conrads, T.P., Maxwell, G.L.Volume:
154
Langue:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2019.04.142
Date:
June, 2019
Fichier:
PDF, 419 KB
english, 2019